Acadian Asset Management LLC Bio N Tech Se Transaction History

Acadian Asset Management LLC

$32.5 Billion
Q2 2024

A detailed history of Acadian Asset Management LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Acadian Asset Management LLC holds 4,286 shares of BNTX stock, worth $509,048. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,286

Previous 111,398 96.15%

Holding current value

$509,048

Previous $10.3 Million 96.65%

% of portfolio

0.0%

Previous 0.04%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$80.36 - $102.87 $8.61 Million - $11 Million	-107,112 Reduced 96.15%	4,286 $344,000
Q1 2024 May 10, 2024	BUY	$88.96 - $112.35 $3.36 Million - $4.25 Million	37,792 Added 51.34%	111,398 $10.3 Million
Q4 2023 Feb 13, 2024	SELL	$90.91 - $112.75 $3.86 Million - $4.79 Million	-42,465 Reduced 36.59%	73,606 $7.77 Million
Q3 2023 Nov 13, 2023	SELL	$98.5 - $125.08 $2.47 Million - $3.14 Million	-25,095 Reduced 17.78%	116,071 $12.6 Million
Q2 2023 Aug 07, 2023	BUY	$102.58 - $129.66 $3.08 Million - $3.89 Million	30,039 Added 27.03%	141,166 $15.2 Million
Q1 2023 May 11, 2023	SELL	$122.57 - $153.67 $24.6 Million - $30.9 Million	-201,037 Reduced 64.4%	111,127 $13.8 Million
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $25.7 Million - $40.4 Million	217,092 Added 228.34%	312,164 $46.9 Million
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $3.71 Million - $5.32 Million	29,054 Added 44.01%	95,072 $12.8 Million
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $3.71 Million - $5.32 Million	29,054 Added 44.01%	95,072 $12.8 Million
Q2 2022 Aug 09, 2022	BUY	$123.25 - $186.24 $8.12 Million - $12.3 Million	65,853 Added 39910.91%	66,018 $9.84 Million
Q1 2022 May 12, 2022	SELL	$126.25 - $231.85 $568,251 - $1.04 Million	-4,501 Reduced 96.46%	165 $28,000
Q4 2021 Feb 10, 2022	SELL	$216.64 - $362.52 $55.2 Million - $92.3 Million	-254,709 Reduced 98.2%	4,666 $1.15 Million
Q3 2021 Nov 12, 2021	SELL	$205.93 - $447.23 $84.1 Million - $183 Million	-408,457 Reduced 61.16%	259,375 $71 Million
Q2 2021 Aug 11, 2021	BUY	$113.32 - $241.49 $75.7 Million - $161 Million	667,832 New	667,832 $150 Million

Others Institutions Holding BNTX

# of Institutions

328

Shares Held

40.6M

Call Options Held

845K

Put Options Held

1.23M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.8B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account

Acadian Asset Management LLC Bio N Tech Se Transaction History